ACOGAlpha Cognition Inc. Common Stock

9.750USDMkt Cap: 212.33M $P/E:

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development pro…

Key Statistics

Company
Market Cap212.33M $
Enterprise Value170.95M $
Revenue (TTM)15.26M $
Gross Profit8.30M $
Net Income (TTM)-20.67M $
Revenue/Share0.7420 USD
Last Price9.750 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees71
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-15.73
PEG
EV/EBITDA-6.45
EV/Revenue11.20
P/S13.91
P/B3.39
EPS (TTM)-0.96
EPS (Forward)-0.62
52W Range
9.36053% of range10.10
52W High10.10 USD
52W Low9.360 USD
Profitability
Gross Margin81.26%
Oper. Margin-127.29%
EBITDA Margin-173.57%
Profit Margin-202.24%
ROE-33.06%
ROA-25.92%
Growth
Revenue Growth267.60%
Earnings Growth
Cash Flow & Leverage
Operating CF-20.38M $
CapEx (TTM)293.49K $
FCF Margin-186.95%
FCF Yield-13.44%
Net Debt-41.38M $
Net Debt/EBITDA1.56
Balance Sheet
Debt/Equity
Current Ratio9.03
Quick Ratio7.31
Book Value/Sh2.872 USD
Cash/Share1.900 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)18.00 USD
Upside (mean)+84.6%
Target Range12.00 USD21.00 USD
$12.00+84.6% to mean$21.00
# Analysts5
Ownership
Shares Out.21.78M
Float11.62M
Insiders5.28%
Institutions53.32%
Short Interest
Short Ratio1.9d
Short % Float1.06%
Short % Out.0.85%
Shares Short184.59K
Short (prev mo.)129.90K
Technical
SMA 507.995 (+21.9%)
SMA 2006.433 (+51.6%)
Beta2.23
S&P 52W Chg19.18%
Avg Vol (30d)294.21K
Avg Vol (10d)191.89K
Technical Indicators
RSI (14)66.6
MACD0.3459
MACD Signal0.3142
MACD Hist.+0.0316
BB Upper9.516 USD
BB Middle8.812 USD
BB Lower8.108 USD
BB Width15.98%
ATR (14)0.7413 USD
Vol Ratio (20d)2.38x